Literature DB >> 18273596

[Extended sentinel lymph node dissection in radical prostatectomy for prostate cancer: a study in the Kiel risk population].

S Hautmann1, S Beitz, M Naumann, U Lützen, C Seif, S H Stübinger, C van der Horst, P M Braun, I Leuschner, E Henze, K P Jünemann.   

Abstract

Extended lymph node dissection during radical prostatectomy for prostate cancer remains a disputed area. Sentinel lymph scans help identify the first lymph node stages in the lymph drainage of the prostate. This study was designed to investigate the detection rate of lymph node metastasis by extended lymph node dissection and sentinel lymph node scanning in patients undergoing radical retropubic prostatectomy (RRP) for localized prostate cancer. In this study at our department from 2005 to 2006, a total of 108 patients with localized prostate carcinoma were treated with radical prostatectomy including extended lymph node dissection. A sentinel lymph node scan with 160 MBq of technetium-99m-Nanocoll (Tc) was performed 1 day before surgery. A C-Trak gamma probe (AEA Technologies, Morgan Hills, CA, USA) was used intraoperatively to detect the sentinel lymph nodes. Scan findings were correlated with tumor stage, Gleason score, prostate-specific antigen (PSA) level, and histological lymph node status. Scans revealed sentinel lymph nodes on the film 2 h after Tc administration in 98 of 108 patients (91%). Histologically proven lymph node metastases were detected in 15 of those 98 patients (15%) with a positive sentinel scan. Those 15 patients had a PSA level greater than 10 ng/ml or a Gleason score greater than 6 and at least a pT2 tumor. Specifically, six patients had a pT2 tumor, and nine patients had a pT3 tumor. Of patients placed in a risk group defined as PSA above 10 ng/ml or Gleason score greater than 6, 15 out of 50 patients (30%) had sentinel positive lymph nodes with metastasis. These data suggest that extended sentinel lymph node dissection helps identify lymph node metastasis in patients with PSA above 10 ng/ml or a Gleason score above 6 in 30% of cases. Further studies will show whether these numbers will hold true in patients undergoing radical prostatectomy for prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18273596     DOI: 10.1007/s00120-008-1652-2

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  8 in total

1.  Observations on a "sentinel node" in cancer of the parotid.

Authors:  E A GOULD; T WINSHIP; P H PHILBIN; H H KERR
Journal:  Cancer       Date:  1960 Jan-Feb       Impact factor: 6.860

2.  Limitations of radioguided surgery in high-risk prostate cancer.

Authors:  Dorothea Weckermann; Robert Dorn; Gabriele Holl; Theodor Wagner; Rolf Harzmann
Journal:  Eur Urol       Date:  2006-09-11       Impact factor: 20.096

3.  The sentinel lymph node concept in prostate cancer - first results of gamma probe-guided sentinel lymph node identification.

Authors:  F Wawroschek; H Vogt; D Weckermann; T Wagner; R Harzmann
Journal:  Eur Urol       Date:  1999-12       Impact factor: 20.096

4.  Detection of sentinel node micrometastasis by step section and immunohistochemistry in patients with prostate cancer.

Authors:  Mamoru Fukuda; Masayuki Egawa; Tetsuya Imao; Hiroshi Takashima; Kunihiko Yokoyama; Mikio Namiki
Journal:  J Urol       Date:  2007-04       Impact factor: 7.450

5.  Laparoscopic radioisotope-guided sentinel lymph node dissection in staging of prostate cancer.

Authors:  Stephan Jeschke; Avi Beri; Martin Grüll; Josef Ziegerhofer; Peter Prammer; Karl Leeb; Wolfgang Sega; Guenter Janetschek
Journal:  Eur Urol       Date:  2007-03-28       Impact factor: 20.096

6.  Radioisotope guided pelvic lymph node dissection for prostate cancer.

Authors:  F Wawroschek; H Vogt; D Weckermann; T Wagner; M Hamm; R Harzmann
Journal:  J Urol       Date:  2001-11       Impact factor: 7.450

7.  Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.

Authors:  Dorothea Weckermann; Robert Dorn; M Trefz; Theodor Wagner; Friedhelm Wawroschek; Rolf Harzmann
Journal:  J Urol       Date:  2007-03       Impact factor: 7.450

8.  Prostate lymphoscintigraphy and radio-guided surgery for sentinel lymph node identification in prostate cancer. Technique and results of the first 350 cases.

Authors:  Friedhelm Wawroschek; Harry Vogt; Hermann Wengenmair; Dorothea Weckermann; Michael Hamm; Mathias Keil; Gerhard Graf; Peter Heidenreich; Rolf Harzmann
Journal:  Urol Int       Date:  2003       Impact factor: 2.089

  8 in total
  4 in total

Review 1.  [Intermediate and high risk prostate cancer patients. Clinical significance of extended lymphadenectomy].

Authors:  D K Osmonov; A Boller; A Aksenov; M Naumann; K P Jünemann
Journal:  Urologe A       Date:  2013-02       Impact factor: 0.639

Review 2.  Sentinel node biopsy and lymphatic mapping in penile and prostate cancer.

Authors:  H G van der Poel; P Meershoek; N Grivas; G KleinJan; F W B van Leeuwen; S Horenblas
Journal:  Urologe A       Date:  2017-01       Impact factor: 0.639

Review 3.  A comprehensive overview of radioguided surgery using gamma detection probe technology.

Authors:  Stephen P Povoski; Ryan L Neff; Cathy M Mojzisik; David M O'Malley; George H Hinkle; Nathan C Hall; Douglas A Murrey; Michael V Knopp; Edward W Martin
Journal:  World J Surg Oncol       Date:  2009-01-27       Impact factor: 2.754

4.  Extended salvage pelvic lymph node dissection in patients with recurrent prostate cancer.

Authors:  Daniar K Osmonov; Alexey V Aksenov; Annkathrin Boller; Almut Kalz; Diana Heimann; Isa Janssen; Klaus-Peter Jünemann
Journal:  Adv Urol       Date:  2014-02-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.